We and other researchers [5,6,27,28] have shown a significantly lower prevalence of anti-Ro/SS-A and anti-La/SS-B autoantibodies among ACA+/SS compared to ACA-/SS patients. The gene discussed is CALR; the disease is synovial sarcoma.